Shattuck Labs, Inc. (STTK): Total Assets
$91.03M
As of 2025-12-31
$220.67M
As of 2026-06-30
-23.7%
3-year compound annual growth
-23.6%
5-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $91.03M | 0.0% | 2026-03-05, Balance as of period end |
| 2024-12-31 | $91.05M | -42.9% | 2026-03-05, Balance as of period end |
| 2023-12-31 | $159.56M | -22.3% | 2025-03-27, Balance as of period end |
| 2022-12-31 | $205.32M | -31.2% | 2024-02-29, Balance as of period end |
| 2021-12-31 | $298.58M | -14.4% | 2023-02-23, Balance as of period end |
| 2020-12-31 | $348.99M | +676.1% | 2022-03-15, Balance as of period end |
| 2019-12-31 | $44.97M | n/a | 2021-03-16, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Shattuck Labs, Inc. (STTK) | 2025-12-31 | $91.03M | 0.0% |
| 60 Degrees Pharmaceuticals, Inc. (SXTP) | 2025-12-31 | $5.37M | -6.8% |
| Dare Bioscience, Inc. (DARE) | 2025-12-31 | $32.47M | +46.9% |
| Rafael Holdings, Inc. (RFL) | 2025-07-31 | $114.11M | +17.8% |
| Bespoke Extracts, Inc. (BSPK) | 2024-12-31 | $359.1K | +1.3% |
| China SXT Pharmaceuticals, Inc. (SXTC) | 2026-03-31 | $34.75M | +60.4% |
| Rallybio Corp (RLYB) | 2025-12-31 | $62.26M | -8.6% |
| Neuphoria Therapeutics Inc. (NEUP) | 2026-06-30 | $28.71M | +0.4% |
| Longeveron Inc. (LGVN) | 2025-12-31 | $10.26M | -59.9% |
Compare STTK, SXTP, DARE, RFL side by side · Screen every company in Pharmaceutical Preparations ↗